Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02104076 · ClinicalTrials.gov registry record · NA
Evolution® Biliary Stent System-Fully Covered
A NA study, sponsored by Cook Group Incorporated.
- Completed
- Registry status
- NA
- Development phase
- 90
- Enrollment target
NCT02104076 is a NA study that has completed, run by Cook Group Incorporated. The registered enrollment target is 90 participants.
The verdict
NCT02104076, a NA study, has completed, sponsored by Cook Group Incorporated.
- COMPLETED
- Registry status
- NA
- Development phase
- 90 participants
- Enrollment target
Study Summary
The Evolution® Biliary Stent System-Fully Covered study is a clinical trial approved by the US FDA to evaluate the effectiveness of the Evolution® Biliary Stent System-Fully Covered when used in palliation of malignant neoplasms in the biliary tree.
Interventions
- DEVICE Evolution® Biliary Stent-Fully Covered
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 90 participants |
| Start Date | 2014-09 |
| Est. Completion | 2017-01-04 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02104076
The ClinicalTrials.gov registry entry for NCT02104076 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 90 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Cook Group Incorporated, which has 31 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Evolution® Biliary Stent-Fully Covered is the first listed.
NCT02104076 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02104076 about?
NCT02104076 is a clinical study titled "Evolution® Biliary Stent System-Fully Covered". The Evolution® Biliary Stent System-Fully Covered study is a clinical trial approved by the US FDA to evaluate the effectiveness of the Evolution® Biliary Stent System-Fully Covered when used in palliation of malignant neoplasms in the biliary tree.
What is the current status of trial NCT02104076?
This trial is currently completed. It is a NA study. The enrollment target is 90 participants. The study started on 2014-09. Estimated completion is 2017-01-04.
What interventions are being tested in trial NCT02104076?
The interventions under investigation include: Evolution® Biliary Stent-Fully Covered (DEVICE).
Who is sponsoring clinical trial NCT02104076?
This trial is sponsored by Cook Group Incorporated, which has 31 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.